Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1485 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
bioMérieux S.A.. (9/3/14). "Press Release: First-half 2014 Results". Marcy l’Étoile. 2014-09-03
Cepheid. (9/3/14). "Press Release: Cepheid Announces European Release of Xpert TV, a Next-Generation Molecular Test for Rapid and Accurate Identification of Trichomonas vaginalis Infections". Sunnyvale, CA. 2014-09-03
Vygon S.A.. (9/2/14). "Press Release: Vygon Group Buys Medwin". Ecouen. 2014-09-02
Cepheid. (9/2/14). "Press Release: Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection". Sunnyvale, CA. 2014-09-02
Median Technologies S.A.. (8/25/14). "Press Release: Median Technologies Announces a Reserved Capital Increase of €20 Million. Investment Led by New Enterprise Associates (NEA), a Leading US Healthcare Investor". Sophia Antipolis. 2014-08-25
Valneva S.E.. (8/8/14). "Press Release: Valneva Reports H1 2014 Results, Confirms Full Year Outlook, and Provides Business Update". Lyon. 2014-08-08
Cellectis S.A.. (7/31/14). "Press Release: Pfizer’s Stake in Cellectis’ Capital Is Welcomed by Its Shareholders". Paris. 2014-07-31
Cellectis S.A.. (7/29/14). "Press Release: Cellectis Sells Its Swedish Subsidiary, Cellectis AB, to the Japanese Company Takara Bio Inc.". Paris. 2014-07-29
bioMérieux, Inc.. (7/23/14). "Press Release: bioMérieux Virtuo, the New Generation of Blood Culture System, Is CE-marked". Marcy l’Étoile. 2014-07-23
Novasep S.A.. (7/22/14). "Press Release: Novasep Passes FDA Inspections on Two Sites. Novasep Wins Approval to Produce New Molecular Entity for US Market". Pompey. 2014-07-22
bioMérieux S.A.. (7/17/14). "Press Release: Second-Quarter 2014 Business Review – Solid Growth in First-half Sales ". Marcy l’Étoile. 2014-07-17
Innate Pharma S.A.. (6/24/14). "Press Release: Innate Pharma Raises 50 Million Euros in a Capital Increase Subscribed by Specialist Institutional Investors [Not for Canada, Australia or Japan]". Marseille. 2014-06-24
Innate Pharma S.A.. (6/19/14). "Press Release: Innate Pharma Launches a Capital Increase to Raise Up to 15% of Current Capital [Not for Canada, Australia or Japan]". Marseille. 2014-06-19
Pfizer Inc.. (6/18/14). "Press Release: Pfizer and Cellectis Enter into Global Strategic Cancer Immunotherapy Collaboration". 2014-06-18
Pixium Vision S.A.. (6/17/14). "Press Release: Pixium Vision Raises €34.5 Million (US$ 46.7 Million) in Successful IPO on Euronext Paris, after Full Exercise of the Extension Clause". Paris. 2014-06-17
Prestodiag S.A.S.. (6/10/14). "Press Release: Prestodiag Raises €2.2 Million Euro to Market Its Innovative Solutions for Microbiological Analysis". Paris. 2014-06-10
Cellectis S.A.. (6/5/14). "Press Release: Cellectis and Thermo Fisher Scientific Enter Into Agreements on TALEN, a Leading Gene Editing Technology". Carlsbad, CA & Paris. 2014-06-05
Provence Technologies. (6/2/14). "Press Release: Provence Technologies Acquires Synprosis". Marseille. 2014-06-02
bioMérieux S.A.. (5/28/14). "Press Release: The General Shareholders’ Meeting of bioMérieux Approves the Appointment of Two New Independent Directors". Marcy l’Étoile. 2014-05-28
Lysogene. (5/21/14). "Press Release: Lysogene Raises a 16.5 M€ Series A Led by Sofinnova Partners and Co-led by Innobio and Novo Seeds". Paris. 2014-05-21
Biovision (Fondation pour l’Universite de Lyon / Andrew Lloyd & Associates). (5/19/14). "Press Release: Biovision Presents Its Selection of 44 Promising Life Sciences Businesses and Projects". Lyon. 2014-05-19
Enterome Bioscience S.A.. (5/1/14). "Press Release: Enterome Raises €10 Million in Series B Fund Raising". Paris. 2014-05-01
Sartorius AG. (4/28/14). "Press Release: Sartorius Stedim Biotech Acquires Majority Stake in U.S. Start-up AllPure Technologies. Takeover Extends Sartorius Stedim Biotech Portfolio for Single-use Bioprocessing". Aubagne. 2014-04-28
Sartorius AG. (4/28/14). "Press Release: First-quarter Figures – Sartorius Stedim Biotech Off to a Good Start in 2014". 2014-04-28
bioMérieux S.A.. (4/23/14). "Press Release: First-quarter 2014 Business Review". Marcy l’Étoile. 2014-04-23
Transgene S.A.. (4/22/14). "Press Release: Transgene Reports First Quarter 2014 Financial Results. Circa € 100 Million in Cash as of March 31". Strasbourg. 2014-04-22
BioAlliance Pharma S.A.. (4/16/14). "Press Release: BioAlliance Pharma and Topotarget Enter into Merger Agreement to Create a Leading Orphan Oncology Company". Paris & Copenhagen. 2014-04-16
Theradiag S.A.. (4/16/14). "Press Release: Theradiag Secures a Standby Equity Facility (SEF) with Société Générale". Croissy-Beaubourg & Montpellier. 2014-04-16
AAVLife. (4/15/14). "Press Release: AAVLife Raises $12 Million in Series A Financing to Advance Gene Therapy for Friedreich’s Ataxia". Paris. 2014-04-15
bioMérieux S.A.. (4/15/14). "Press Release: Alexandre Mérieux Assumes Role of bioMérieux CEO". Marcy l’Étoile. 2014-04-15
Vexim S.A.. (4/15/14). "Press Release: Vexim Doubles Its Sales in the 1st Quarter of 2014, to €2.1m". Toulouse. 2014-04-15
IntegraGen S.A.. (4/15/14). "Press Release: Annual Results 2013". Evry. 2014-04-15
TxCell S.A.. (4/14/14). "Press Release: TxCell Completes IPO on Euronext, Raising EUR 16.2 Million [only for relevant persons]". Valbonne. 2014-04-14
Novasep S.A.. (5/15/14). "Press Release: Novasep’s EUR 4 Million Plant Extension for Commercial ADC Payload Manufacturing Now Commissioned". Pompey. 2014-04-14
Nanobiotix S.A.. (4/11/14). "Press Release: 2013 Annual Results". Paris. 2014-04-11
Immutep S.A.. (4/8/14). "Press Release: Immutep and Eddingpharm Start Production of ImmuFact IMP321 at WuXi AppTec in China". Orsay & Shanghai. 2014-04-08
Theradiag S.A.. (4/8/14). "Press Release: Theradiag Signs a Fourth microRNA Partnership Agreement with CNRS". Croissy-Beaubourg & Montpellier. 2014-04-08
Genticel S.A.. (4/4/14). "Press Release: Genticel Lists on Euronext in Paris and Brussels". 2014-04-04
IntegraGen S.A.. (4/3/14). "Press Release: IntegraGen Announces Collaborative Agreement with Pfizer to Evaluate IntegraGen’s Proprietary Hepatocellular Carcinoma Molecular Signature". 2014-04-03
Novasep S.A.. (3/27/14). "Press Release: Novasep Reports Full Year 2013 Results Showing Strong Growth and Beating Guidance". 2014-03-27
Neovacs S.A.. (3/27/14). "Press Release: Financial Results for 2013". Paris. 2014-03-27
Adocia S.A.. (3/25/14). "Adocia Announces Financial Results for 2013. A Cash Position of EUR 19.4M at End of December 2013". Lyon. 2014-03-25
IntegraGen S.A.. (3/24/14). "Press Release: IntegraGen and Gustave Roussy Announce the Set-up of a High-throughput Clinical Sequencing Unit". Villejuif. 2014-03-24
Transgene S.A.. (3/24/14). "Press Release: Transgene Successfully Completes Rights Issue and Private Placement. Total of €65.5 Million Raised [Not for distribution in or into Canada, Japan or Australia]". Strasbourg. 2014-03-24
Valneva S.E.. (3/24/14). "Press Release: Valneva Reports Annual Results 2013. Company Sees First Year of Merger as Operational and Human Success". Lyon. 2014-03-24
Valneva S.E.. (3/24/14). "Press Release: Valneva Announces Continuation of the Phase II/III Clinical Trial for Its Pseudomonas Aeurginosa Vaccine Candidate". Lyon. 2014-03-24
Theradiag S.A.. (3/21/14). "Press Release: Theradiag Selected as a Partner of the ABIRISK Project, the First Consortium of Pharmaceuticals and Academic Experts Dedicated to the Monitoring of Biotherapies". Croissy-Beaubourg & Montpellier. 2014-03-21
Adocia S.A.. (3/20/14). "Press Release: Adocia Confirms Positive Clinical Results for Its BioChaperone Combo, a Combination of Long-acting Insulin Glargine and Fast-acting Insulin Lispro". Lyon. 2014-03-20
bioMérieux S.A.. (3/19/14). "Press Release: 2013 Financial Results". Marcy l’Étoile. 2014-03-19
Inserm Transfert. (3/18/14). "Press Release: Mrs Pascale Augé Appointed as Chief Executive Officer, Inserm Transfert". 2014-03-18
Inserm Transfert. (3/18/14). "Press Release: Cécile Tharaud Appointed as President and Managing Partner of Inserm Transfert Initiative". 2014-03-18
Inotrem S.A.. (3/13/14). "Press Release: Inotrem Raises EUR18 Million to Develop Innovative Sepsis Treatments in a Series A Financing Co-led by Edmond de Rothschild Investment Patners and Sofinnova Partners". Paris & Nancy. 2014-03-13
Innovative Medicines Initiative (IMI). (3/11/14). "Press Release: New IMI Project to Incorporate Real Life Data into Drug Development". Brussels. 2014-03-11
Sanofi S.A.. (3/11/14). "Press Release: Sanofi and UCB Partner for Breakthrough Innovation in Immune-mediated Diseases". Paris. 2014-03-11
Bureau Veritas S.A.. (3/6/14). "Press Release: Solid Financial Performance in 2013. Revenue of EUR 3.9 Billion, +5.5% at Constant Currencies". 2014-03-06
Curie-Cancer. (3/5/14). "Press Release: Curie-Cancer and DNA Therapeutics Partner in the Fight against Cancers that Resist Conventional Therapies". Paris & Evry. 2014-03-05
Novasep S.A.. (3/4/14). "Press Release: Novasep Appoints CEO Michel Spagnol as Chairman of the Supervisory Board, Novasep Presents Strategic Developments". Pompey. 2014-03-04
Ynsect S.A.. (3/4/14). "Press Release: Ynsect Raises 1.8 Million Euro in Series A Funding to Develop Insect Biorefineries". 2014-03-04
GamaMabs Pharma S.A.. (3/3/14). "Press Release: GamaMabs Pharma Announces Two Financings Totaling €1.1 Million". Toulouse. 2014-03-03
Transgene S.A.. (2/28/14). "Press Release: Transgene Launches a Rights Issue of 45.5 Million Euros at a Price of 10 Euros per Share [Not for distribution into Canada, Japan or Australia]". Strasbourg. 2014-02-28
Adocia S.A.. (2/27/14). "Press Release: Adocia Announces Preliminary Positive Clinical Results for Its Combination of Long-acting Insulin Glargine and Fast-acting Insulin Analog Lispro, BioChaperone Combo". Lyon. 2014-02-27
bioMérieux S.A.. (2/26/14). "Press Release: bioMérieux Strengthens Its Clostridium difficile Offer with the Launch of VIDAS C. difficile GDH". Marcy l’Étoile. 2014-02-26
Transgene S.A.. (2/25/14). "Press Release: Transgene Announces Plans for a Phase 1b/2 Trial with Pexa-Vec in Advanced Solid Tumors". Strasbourg. 2014-02-25
Adocia S.A.. (2/18/14). "Press Release: Adocia – Annual Revenue of EUR 5.6 M in 2013. The cash position of the Company Amounts to EUR 19.4 M". Lyon. 2014-02-18
Polyplus-transfection S.A.. (2/17/14). "Press Release: Polyplus-transfection and the National Institute of Health Sign a Research License Agreement for PEI-based Transfection Technologies". Strasbourg. 2014-02-17
Truffle Capital. (2/12/14). "Press Release: Creation of Abivax – a Leader in Therapeutic Vaccines and the First French Company to Sign an Exclusive Partnering Agreement with Cuba in Healthcare". Paris. 2014-02-12
Biovision. (2/11/14). "Press Release: Biovision Will Explore Ways to Identify and Fund Disruptive Innovation in Healthcare – June 5 and 6 2014". Lyon. 2014-02-11
Innate Pharma S.A.. (2/11/14). "Press Release: Annual Results for 2013. Cash Position Strengthened to €41.3m as at December 31, 2013". Marseille. 2014-02-11
Cellectis S.A.. (2/4/14). "Press Release: Cellectis Grants genOway an Exlusive Sublicense for Its Homologous Recombination Technology in the Field of Genetically Modified Rodent Models". Paris. 2014-02-04
Bureau Veritas S.A.. (2/3/14). "Press Release: Bureau Veritas Completes the Acquisition of Maxxam, Canada’s Market Leader in Analytical Services". Neuilly-sur-Seine. 2014-02-03
Dassault Systèmes S.A.. (1/30/14). "Press Release: Dassault Systèmes and Accelrys to Join Forces". Vélizy-Villacoublay & San Diego, CA. 2014-01-30
Cellectis S.A.. (1/30/14). "Press Release: Precision BioSciences and Cellectis SA Announce Cross-license and Settlement Agreement for Gene Editing Technology". Research Triangle Park, NC & Carlsbad, CA. 2014-01-30
Curie-Cancer. (1/28/14). "Press Release: Curie-Cancer and Servier Continue a Renewed Partnership in Cancer Research". Paris & Suresnes. 2014-01-28
Sartorius AG. (1/28/14). "Press Release: Sartorius Stedim Biotech – Preliminary Results 2013". Göttingen. 2014-01-28
Hybrigenics S.A.. (1/27/14). "Press Release: Hybrigenics – Strong 22% Increase in 2013 Operating Revenues". Paris. 2014-01-27
bioMérieux S.A.. (1/27/14). "Press Release: Appointment of Claire Giraut as bioMérieux's Corporate Vice President and Chief Financial Officer". Marcy L’Étoile. 2014-01-27
bioMérieux S.A.. (1/22/14). "Press Release: bioMérieux – Business Review for the Year ended December 31, 2013". Marcy L’Étoile. 2014-01-22
Hybrigenics S.A.. (1/20/14). "Press Release: Hybrigenics Achieves First Research Milestone for Servier". Paris. 2014-01-20
Cellectis S.A.. (1/17/14). "Press Release: Axxam and Cellectis Bioresearch Announce Their Collaboration to Offer a New Generation of Cell Based Assays". Allschwil. 2014-01-17
bioMérieux S.A.. (1/16/14). "Press Release: bioMérieux Finalizes Acquisition of the U.S. Company BioFire, Specialized in Molecular Biology". Marcy l’Étoile. 2014-01-16
Novasep S.A.. (1/16/14). "Press Release: Novasep Attracts Top Talent to Complete Its Executive Team. Thierry Van Nieuwenhove, a Seasoned CMO Top Executive, Joins Novasep as President of the Synthesis Business Unit". Pompey. 2014-01-16
Advanced Chemistry Development, Inc. (ACD/Labs). (1/13/14). "Press Release: Advancing Natural Products Research with ACD/NMR Workbook Suite. Customized and Trainable NMR Prediction Database". Toronto, ON. 2014-01-13
Edmond de Rothschild Investment Partners. (1/9/14). "Press Release: The Edmond de Rothschild Group Appoints a New Partner to Its Life Science Venture Capital Business". 2014-01-09
Hybrigenics S.A.. (1/8/14). "Press Release: Etienne Formstecher Is Appointed as CEO of Hybrigenics Services". Paris. 2014-01-08
Cellectis S.A.. (1/7/14). "Press Release: Cellectis Reorganizes Its Tools and Services Business Line, in Partnership with Caisse des Dépôts, by Contributiong Ectycell’s Shares to Cellectis Bioresearch". Paris. 2014-01-07
Bureau Veritas S.A.. (12/21/13). "Press Release: Bureau Veritas Has Signed an Agreement to Acquire Maxxam, Canada’s Market Leader in Petroleum, Environmental, Food and DNA Analytical Services". Neuilly-sur-Seine. 2013-12-21
Sanofi S.A.. (12/19/13). "Press Release: Sanofi and Regeneron Announce Collaboration with American College of Cardiology for PCSK9 Inhibitor Clinical Program". Paris & Tarrytown, NY. 2013-12-19
University of Montreal. (12/18/13). "Press Release: Domain Therapeutics, Université de Montréal, IRICoR and McGill University Sign New Licensing and Partnership Agreement on G-Protein Coupled Receptor Biosensor Technology". Strasbourg & Montréal, ON. 2013-12-19
Advanced Chemistry Development, Inc. (ACD/Labs). (12/16/13). "Press Release: The University of Paris Selects ACD/Percepta Software to Enhance Teaching and Research into Pharmaceuticals". Toronto, ON. 2013-12-16
Neovacs S.A.. (12/16/13). "Press Release: Neovacs Secures a Contingent Equity Line". Paris. 2013-12-16
Adocia S.A.. (12/9/13). "Press Release: Adocia Signs an Exclusive License on a Nanotechnology which Improves the Efficacy of Anti-tumoral Agents by Targeting Their Action into Tumors". Lyon. 2013-12-09
Gecko Biomedical. (12/9/13). "Press Release: Gecko Biomedical Raises €8 Million in Series A Financing to Advance Next-generation Tissue Adhesives for Wound Closure during Open and Minimally Invasive Surgery". Paris. 2013-12-09
bioMérieux S.A.. (12/5/13). "Press Release: bioMérieux Is Moving Forward to a New Molecular Biology Workflow Solution for Reference or Centralized Laboratories". Marcy l’Étoile. 2013-12-05
Cellectis S.A.. (12/5/13). "Press Release: Cellectis Announces an Acceleration of Its Strategic Refocusing on Therapeutics and Agrobusiness". Paris. 2013-12-05
Novasep S.A.. (12/3/13). "Press Release: Novasep Launches Chinese Website". Pompey. 2013-12-03
bioMérieux S.A.. (11/28/13). "Press Release: bioMérieux Announces Termination of Its Collaboration with Biocartis in Molecular Biology". Marcy l’Étoile. 2013-11-28
Bioaxial S.A.S.. (11/27/13). "Press Release: Bioaxial Secures EUR 1.9 Million (USD 2.7 Million) in New Funding to Finance the Commercialization of Its First Range of Super-resolved Fluorescence Microscopy Instruments". Paris. 2013-11-27
Clevexel Pharma. (11/25/13). "Press Release: Clevexel Pharma Partners with Dynamix Pharmaceuticals to Develop Novel Oral Treatment for Rheumatoid Arthritis". Maisons-Alfort & Rehovot. 2013-11-25
Pixium Vision. (11/25/13). "Press Release: Pixium Vision Raises €15 Million Led by Sofinnova Partners". Paris. 2013-11-25
Innate Pharma S.A.. (11/20/13). "Press Release: Innate Pharma Raises €20.3 Million in a Private Placement Subscribed Entirely by US-based Specialist Investors". Marseille. 2013-11-20
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top